Shiro Suzuki

4.5k total citations
192 papers, 3.4k citations indexed

About

Shiro Suzuki is a scholar working on Reproductive Medicine, Molecular Biology and Obstetrics and Gynecology. According to data from OpenAlex, Shiro Suzuki has authored 192 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Reproductive Medicine, 51 papers in Molecular Biology and 44 papers in Obstetrics and Gynecology. Recurrent topics in Shiro Suzuki's work include Ovarian cancer diagnosis and treatment (50 papers), Endometrial and Cervical Cancer Treatments (44 papers) and Enzyme function and inhibition (19 papers). Shiro Suzuki is often cited by papers focused on Ovarian cancer diagnosis and treatment (50 papers), Endometrial and Cervical Cancer Treatments (44 papers) and Enzyme function and inhibition (19 papers). Shiro Suzuki collaborates with scholars based in Japan, United States and Australia. Shiro Suzuki's co-authors include Fumitaka Kikkawa, Hiroaki Kajiyama, Kiyosumi Shibata, Kaoru Niimi, Nobuhisa Yoshikawa, M Muranaka, Satoshi Tamauchi, Takuya Miyamoto, K Koizumi and Hiroshi Tokiwa and has published in prestigious journals such as Science, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Shiro Suzuki

182 papers receiving 3.3k citations

Peers

Countries citing papers authored by Shiro Suzuki

Since Specialization

Citations

This map shows the geographic impact of Shiro Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Suzuki more than expected).

Fields of papers citing papers by Shiro Suzuki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiro Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Suzuki. The network helps show where Shiro Suzuki may publish in the future.

Co-authorship network of co-authors of Shiro Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Shiro Suzuki. A scholar is included among the top collaborators of Shiro Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiro Suzuki. Shiro Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnostic accuracy and prognostic factors of uterine serous carcinoma in Japanese women: a multi-center study 2025 ·Journal of Gynecologic Oncology ·Shin Nishio, Kimio Ushijima, Mitsuya Ishikawa, Hideki Tokunaga, Koji Horie, Satoshi Yamaguchi, Shiro Suzuki, Hideaki Yahata, Hitoshi Tsuda, Toyomi Satoh	0
2	Efficient expansion of tumor-infiltrating lymphocytes from gynecologic cancer 2025 ·The Journal of Immunology ·Tetsuya Matsukawa, (unknown), (unknown), Toshiaki Yoshikawa, Yusuke Ito, (unknown), (unknown), (unknown), Tatsuyuki Chiyoda, Hiroshi Nishio, (unknown), Waki Hosoda, Shiro Suzuki, Yuki Kagoya	0
3	Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer 2024 ·Journal of Gynecologic Oncology ·Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, Mayu Yunokawa, Kimio Ushijima, Shiro Suzuki, Ayumi Shikama, Shinichiro Minobe, Tomoka Usami, Jae‐Weon Kim, Byoung‐Gie Kim, Peng‐Hui Wang, Ting‐Chang Chang, Keiko Yamamoto, (unknown), Jodi A. McKenzie, Robert Orlowski, Takuma Miura, Vicky Makker, Yong Man Kim	8
4	Real‐world data of poly (ADP‐ribose) polymerase inhibitor response in Japanese patients with ovarian cancer 2024 ·Cancer Medicine ·(unknown), Akira Yokoi, Eri Watanabe, Kosuke Yoshida, Masato Yoshihara, Satoshi Tamauchi, Yusuke Shimizu, Yoshiki Ikeda, Nobuhisa Yoshikawa, Kaoru Niimi, Shiro Suzuki, Hiroaki Kajiyama	1
5	Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer 2023 ·Journal of Gynecologic Oncology ·(unknown), Eiji Kondo, (unknown), (unknown), Yasuyuki Kishigami, (unknown), Kenji Nagao, Toru Hirata, Shiro Suzuki	4
6	Adjuvant taxane plus platinum chemotherapy for stage I ovarian clear cell carcinoma with complete surgical staging: are more than three cycles necessary? 2021 ·International Journal of Clinical Oncology ·Mayu Ukai, Shiro Suzuki, Masato Yoshihara, Akira Yokoi, Nobuhisa Yoshikawa, Hiroaki Kajiyama, Fumitaka Kikkawa	2
7	Survival after Anticancer Treatment of Terminally Ill Patients with Ovarian Carcinoma 2020 ·Journal of Palliative Medicine ·Hiroaki Kajiyama, Shiro Suzuki, (unknown), Fumi Utsumi, Nobuhisa Yoshikawa, Fumitaka Kikkawa	2
8	The impact of systematic retroperitoneal lymphadenectomy on long-term oncologic outcome of women with advanced ovarian clear-cell carcinoma 2020 ·Journal of Gynecologic Oncology ·Hiroaki Kajiyama, Shiro Suzuki, Nobuhisa Yoshikawa, Satoshi Tamauchi, Kiyosumi Shibata, Fumitaka Kikkawa	9
9	Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma 2019 ·Journal of Gynecologic Oncology ·Kosuke Yoshida, Nobuhisa Yoshikawa, (unknown), Kaoru Niimi, Shiro Suzuki, Hiroaki Kajiyama, Fumitaka Kikkawa	17
10	Prognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clear-cell carcinoma: a propensity score analysis 2019 ·Journal of Gynecologic Oncology ·Masato Yoshihara, Hiroaki Kajiyama, Satoshi Tamauchi, Shiro Suzuki, Kunihiko Takahashi, Shigeyuki Matsui, Fumitaka Kikkawa	24
11	PRIMA-1MET induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells 2016 ·Oncology Reports ·Nobuhisa Yoshikawa, Hiroaki Kajiyama, Kae Nakamura, Fumi Utsumi, Kaoru Niimi, Hiroko Mitsui, (unknown), Shiro Suzuki, Kiyosumi Shibata, David F. Callen, Fumitaka Kikkawa	28
12	Functional interaction between peritoneal mesothelial cells and stem cells of ovarian yolk sac tumor (SC-OYST) in peritoneal dissemination 2011 ·Gynecologic Oncology ·Hiroko Mitsui, Kiyosumi Shibata, Shiro Suzuki, Tomokazu Umezu, Mika Mizuno, Hiroaki Kajiyama, Fumitaka Kikkawa	18
13	HLA‐A2‐restricted glypican‐3 peptide‐specific CTL clones induced by peptide vaccine show high avidity and antigen‐specific killing activity against tumor cells 2011 ·Cancer Science ·Toshiaki Yoshikawa, Munehide Nakatsugawa, Shiro Suzuki, Hirofumi Shirakawa, Daisuke Nobuoka, (unknown), Yutaka Motomura, Yukië Tanaka, Shinichi Hayashi, Tetsuya Nakatsura	66
14	Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery 2011 ·British Journal of Cancer ·Hiroaki Kajiyama, Kiyosumi Shibata, Mika Mizuno, Tomokazu Umezu, Shiro Suzuki, A. Nawa, Michiyasu Kawai, T Nagasaka, Fumitaka Kikkawa	52
15	Identification and characterization of cancer stem cells in ovarian yolk sac tumors 2010 ·Cancer Science ·Shiro Suzuki, Mikio Terauchi, Tomokazu Umezu, Hiroaki Kajiyama, Kiyosumi Shibata, Akihiro Nawa, Fumitaka Kikkawa	17
16	Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients? 2008 ·Annals of Oncology ·Shiro Suzuki, Hiroaki Kajiyama, Kiyosumi Shibata, Kazuhiko Ino, A. Nawa, K Sakakibara, Katsuji Matsuzawa, Akihiro Takeda, Y Kinoshita, Michiyasu Kawai, T Nagasaka, Fumitaka Kikkawa	59
17	Single photon emission computed tomography to determine effective hepatic blood flow and intrahepatic shunting 1995 ·Hepatology ·Motoh Iwasa, (unknown), Tsuyoshi Nakagawa, Shozo Watanabe, Hiroshi Katoh, Yasutomi Kinosada, (unknown), (unknown), Shiro Suzuki	18
18	Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-β 1993 ·Hepatology ·Yoshinao Kobayashi, Shozo Watanabe, Masayoshi Konishi, Masato Yokoi, (unknown), Masahiko Kaito, (unknown), Yuji Hayashi, Takahito Jomori, Shiro Suzuki	132
19	The detection of e-antigen and e-antibody by the radioimmunoassay (Dainabot Co., Ltd.) was investigated and it was compared with the immunodiffusion (ID) method 1980 ·Kanzo ·Hiroshi Suzuki, Shiro Iino, Fumihiro Ichida, Shiro Suzuki, Akira Yoshikawa, Seiichi Furuta, Yoshihiro Akahane, Mineo Kojima, (unknown)	3
20	Liver Functions and Histology in HBV Carriers,with a Special Reference to Comparison with HBs Ag Negative Controls 1979 ·Shiro Suzuki	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact